Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01379664 · ClinicalTrials.gov registry record · NA

Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project

A NA study of Duration of Hospitalization, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
1,584
Enrollment target
1
Study location

NCT01379664 is a NA study of Duration of Hospitalization that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,584 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01379664, a NA study of Duration of Hospitalization, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
1,584 participants
Enrollment target
1
Study location

Study Summary

Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble but more expensive anesthetic sevoflurane. Even a small reduction in the duration of hospitalization would easily compensate for the modest additional cost of sevoflurane. The investigators therefore propose to test the primary hypothesis that duration of hospitalization is longer with isoflurane than sevoflurane. The investigators will also test the secondary hypotheses that: 1) pain scores are greater in patients recovering from isoflurane than sevoflurane anesthesia; and, 2) opioid consumption is greater after isoflurane than sevoflurane anesthesia. All statistical analyses will be adjusted for age, gender, race, baseline risk, 9 and procedure.

Interventions

  • DRUG Sevoflurane
  • DRUG Isoflurane

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 1,584 participants
Start Date 2011-07
Est. Completion 2013-04
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT01379664

The ClinicalTrials.gov registry entry for NCT01379664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,584 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Duration of Hospitalization appearing as the primary indexed condition, and to 2 interventions - of which Sevoflurane is the first listed.

NCT01379664 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01379664 about?

NCT01379664 is a clinical study titled "Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project". Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble but more expensive anesthetic sevoflurane. Even a small reduction in the duration of hospitalization would easily co...

What is the current status of trial NCT01379664?

This trial is currently completed. It is a NA study. The enrollment target is 1,584 participants. The study started on 2011-07. Estimated completion is 2013-04.

What conditions does trial NCT01379664 study?

This clinical trial studies the following conditions: Duration of Hospitalization.

What interventions are being tested in trial NCT01379664?

The interventions under investigation include: Sevoflurane (DRUG), Isoflurane (DRUG).

Who is sponsoring clinical trial NCT01379664?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01379664 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.